Press Release

<< Back
 View printer-friendly version
Editas Medicine to Present at Investor Conferences in March

CAMBRIDGE, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in March.  Details of the presentations are as follows:

Cowen & Company 37th Annual Healthcare Conference
Date:     Monday, March 6, 2017
Time:     2:40 p.m. ET
Location:     Boston
Barclays Global Healthcare Conference 2017
Date:     Thursday, March 16, 2017
Time:     9:30 a.m. ET
Location:     Miami

Live webcasts of the presentations will be available on the Investors & Media section of the Editas website at  Archived replays will be available for approximately 30 days following the respective presentations.

About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.  The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.


Media Contact

Dan Budwick
Pure Communications, Inc.
(973) 271-6085


Editas Investor Contact

Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083


Primary Logo

Editas Medicine